Bridgepoint, an international asset management firm with over €20 billion of assets, announced the acquisition of the PharmaZell Group in February 2020. After obtaining all necessary authorizations, we are very pleased to inform you that the acquisition of the PharmaZell Group by Bridgepoint was successfully completed on May 13th 2020.
For further information please go to www.bridgepoint.eu
The PharmaZell Group is also very pleased to announce that it has fully acquired the PharmaChol Joint Venture on May 13th 2020. The JV was founded in 2016 by PharmaZell and Fayman International (Australia ) and has become one of the major independent crude bile acid producers in the world.